Individual blood–brain barrier phenylalanine transport determines clinical outcome in phenylketonuria
J. Weglage(University of Münster), Harald E. Möller(Max Planck Institute for Human Cognitive and Brain Sciences), Jonas Denecke(Universität Hamburg), Hans‐Georg Koch(University of Freiburg), Dirk Wiedermann(Max Planck Society), Reinhold Feldmann(University of Münster), Erik Harms(University of Münster), Kurt Ullrich(Universität Hamburg)
Cited by 86
Related Papers
Carbohydrate-deficient glycoprotein syndrome type Ib. Phosphomannose isomerase deficiency and mannose therapy.
|Journal of Clinical Investigation|1998|429
MRI of the lungs using hyperpolarized noble gases
|Magnetic Resonance in Medicine|2002|396
Iron, Myelin, and the Brain: Neuroimaging Meets Neurobiology
|Trends in Neurosciences|2019|225
Cortical lamina-dependent blood volume changes in human brain at 7 T
|NeuroImage|2014|191